| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Alector Inc (NASDAQ: ALEC)
ALEC Technical Analysis
5
| As on 9th Jun 2023 ALEC STOCK Price closed @ 7.28 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 12.15 & Strong Sell for SHORT-TERM with Stoploss of 17.56 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALECSTOCK Price
| Open | 7.36 | Change | Price | % |
| High | 7.38 | 1 Day | -0.07 | -0.95 |
| Low | 7.10 | 1 Week | -0.31 | -4.08 |
| Close | 7.28 | 1 Month | 0.81 | 12.52 |
| Volume | 327400 | 1 Year | -15.55 | -68.11 |
| 52 Week High 23.72 | 52 Week Low 5.85 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ALEC Daily Charts |
ALEC Intraday Charts |
Whats New @ Bazaartrend |
ALEC Free Analysis |
|
|
ALEC Important Levels Intraday
| RESISTANCE | 7.82 |
| RESISTANCE | 7.65 |
| RESISTANCE | 7.54 |
| RESISTANCE | 7.43 |
| SUPPORT | 7.13 |
| SUPPORT | 7.02 |
| SUPPORT | 6.91 |
| SUPPORT | 6.74 |
ALEC Forecast April 2024
| 4th UP Forecast | 20.17 |
| 3rd UP Forecast | 16.04 |
| 2nd UP Forecast | 13.48 |
| 1st UP Forecast | 10.93 |
| 1st DOWN Forecast | 3.63 |
| 2nd DOWN Forecast | 1.08 |
| 3rd DOWN Forecast | -1.48 |
| 4th DOWN Forecast | -5.61 |
ALEC Weekly Forecast
| 4th UP Forecast | 13.93 |
| 3rd UP Forecast | 11.80 |
| 2nd UP Forecast | 10.48 |
| 1st UP Forecast | 9.16 |
| 1st DOWN Forecast | 5.40 |
| 2nd DOWN Forecast | 4.08 |
| 3rd DOWN Forecast | 2.76 |
| 4th DOWN Forecast | 0.63 |
ALEC Forecast2024
| 4th UP Forecast | 42.43 |
| 3rd UP Forecast | 31.16 |
| 2nd UP Forecast | 24.19 |
| 1st UP Forecast | 17.22 |
| 1st DOWN Forecast | -2.66 |
| 2nd DOWN Forecast | -9.63 |
| 3rd DOWN Forecast | -16.6 |
| 4th DOWN Forecast | -27.87 |
Alector Inc ( NASDAQ USA Symbol : ALEC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALEC Business Profile
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies; and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies, such as AL001 and AL101 to treat neurodegenerative diseases. The company was founded in 2013 and is headquartered in South San Francisco, California. Address: 131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service